Literature DB >> 33559712

Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study.

Leigh C Casadaban1,2, Paul J Catalano2,3, Leslie K Lee1,2, Hyewon Hyun1,2, Kemal Tuncali1,2, Victor H Gerbaudo1,2, Paul B Shyn4,5.   

Abstract

BACKGROUND: To retrospectively assess liver tumor ablation margins using intraprocedural PET/CT images from FDG PET/CT-guided microwave or cryoablation procedures and to correlate minimum margin measurements with local progression outcomes.
METHODS: Fifty-six patients (ages 36 to 85, median 62; 32 females) with 77 FDG-avid liver tumors underwent 60 FDG PET/CT guided, percutaneous microwave, or cryoablation procedures. Single breath-hold PET/CT images were used for intraprocedural assessment of the tumor ablation margin: liver tumors remained visible on PET immediately following ablation; microwave ablation zones were visible using contrast-enhanced CT; cryoablation zones (ice balls) were visible using unenhanced CT. Two readers retrospectively determined ablation margin assessability and measured the minimum ablation margin on intraprocedural PET/CT (n = 77) and postprocedural MRI (n = 56). Local tumor progression was assessed on all available follow-up imaging (1-49 months, mean 15). Local tumor progression was correlated with PET/CT minimum margin measurements using clustered survival models for 61 tumors.
RESULTS: Minimum ablation margins were more often assessable using intraprocedural PET/CT (≥ 73/77 tumors, 95%) than postprocedural MRI (≤ 35/56 tumors, 63%). In 61 tumors with PET/CT-assessable margins (excluding tumors with overlapping ablations after PET/CT), there was a 6-fold increased risk of local tumor progression [hazard ratio (HR) 6.05; P = 0.004] for minimum ablation margins < 5 mm.
CONCLUSION: Breath-hold PET/CT scans, during PET/CT-guided microwave or cryoablation procedures for FDG-avid liver tumors, enable reliable intraprocedural assessment of the entire tumor ablation margin; a minimum PET/CT ablation margin threshold of 5 mm correlates well with local tumor progression outcomes.

Entities:  

Keywords:  Interventional oncology; Liver tumor ablation; PET/CT; Tumor ablation margin

Mesh:

Substances:

Year:  2021        PMID: 33559712     DOI: 10.1007/s00259-021-05206-5

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  25 in total

1.  Tissue contraction caused by radiofrequency and microwave ablation: a laboratory study in liver and lung.

Authors:  Christopher L Brace; Teresa A Diaz; J Louis Hinshaw; Fred T Lee
Journal:  J Vasc Interv Radiol       Date:  2010-05-27       Impact factor: 3.464

2.  Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases.

Authors:  Xiaodong Wang; Constantinos T Sofocleous; Joseph P Erinjeri; Elena N Petre; Mithat Gonen; Kinh G Do; Karen T Brown; Anne M Covey; Lynn A Brody; William Alago; Raymond H Thornton; Nancy E Kemeny; Stephen B Solomon
Journal:  Cardiovasc Intervent Radiol       Date:  2012-04-26       Impact factor: 2.740

3.  Quantification of tissue shrinkage and dehydration caused by microwave ablation: experimental study in kidneys for the estimation of effective coagulation volume.

Authors:  Christof M Sommer; Steffen A Sommer; Theresa Mokry; Theresa Gockner; Daniel Gnutzmann; Nadine Bellemann; Anne Schmitz; Boris A Radeleff; Hans U Kauczor; Ulrike Stampfl; Philippe L Pereira
Journal:  J Vasc Interv Radiol       Date:  2013-06-20       Impact factor: 3.464

4.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.

Authors:  Jorge A Marrero; Laura M Kulik; Claude B Sirlin; Andrew X Zhu; Richard S Finn; Michael M Abecassis; Lewis R Roberts; Julie K Heimbach
Journal:  Hepatology       Date:  2018-08       Impact factor: 17.425

5.  Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome.

Authors:  Vlasios S Sotirchos; Lydia M Petrovic; Mithat Gönen; David S Klimstra; Richard K G Do; Elena N Petre; Alessandra R Garcia; Afsar Barlas; Joseph P Erinjeri; Karen T Brown; Anne M Covey; William Alago; Lynn A Brody; Ronald P DeMatteo; Nancy E Kemeny; Stephen B Solomon; Katia O Manova-Todorova; Constantinos T Sofocleous
Journal:  Radiology       Date:  2016-03-24       Impact factor: 11.105

6.  Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update.

Authors:  Muneeb Ahmed; Luigi Solbiati; Christopher L Brace; David J Breen; Matthew R Callstrom; J William Charboneau; Min-Hua Chen; Byung Ihn Choi; Thierry de Baère; Gerald D Dodd; Damian E Dupuy; Debra A Gervais; David Gianfelice; Alice R Gillams; Fred T Lee; Edward Leen; Riccardo Lencioni; Peter J Littrup; Tito Livraghi; David S Lu; John P McGahan; Maria Franca Meloni; Boris Nikolic; Philippe L Pereira; Ping Liang; Hyunchul Rhim; Steven C Rose; Riad Salem; Constantinos T Sofocleous; Stephen B Solomon; Michael C Soulen; Masatoshi Tanaka; Thomas J Vogl; Bradford J Wood; S Nahum Goldberg
Journal:  Radiology       Date:  2014-06-13       Impact factor: 11.105

7.  PET/CT-guided radiofrequency and cryoablation: is tumor fluorine-18 fluorodeoxyglucose activity dissipated by thermal ablation?

Authors:  Nisha I Sainani; Paul B Shyn; Servet Tatli; Paul R Morrison; Kemal Tuncali; Stuart G Silverman
Journal:  J Vasc Interv Radiol       Date:  2011-03       Impact factor: 3.464

Review 8.  Imaging Modalities for Assessment of Treatment Response to Nonsurgical Hepatocellular Carcinoma Therapy: Contrast-Enhanced US, CT, and MRI.

Authors:  Yasunori Minami; Masatoshi Kudo
Journal:  Liver Cancer       Date:  2015-04-08       Impact factor: 11.740

9.  Comparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastases.

Authors:  Kyung Ho Kim; Yong Sik Yoon; Chang Sik Yu; Tae Won Kim; Hye Jin Kim; Pyo Nyun Kim; Hyun Kwon Ha; Jin Cheon Kim
Journal:  J Korean Surg Soc       Date:  2011-07-11

Review 10.  Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis.

Authors:  Martijn R Meijerink; Robbert S Puijk; Aukje A J M van Tilborg; Kirsten Holdt Henningsen; Llenalia Garcia Fernandez; Mattias Neyt; Juanita Heymans; Jacqueline S Frankema; Koert P de Jong; Dick J Richel; Warner Prevoo; Joan Vlayen
Journal:  Cardiovasc Intervent Radiol       Date:  2018-04-17       Impact factor: 2.740

View more
  3 in total

Review 1.  Nuclear Cardiac Imaging in the Interventional Suite.

Authors:  Zachary Pickell; Albert J Sinusas
Journal:  Curr Cardiol Rep       Date:  2022-01-13       Impact factor: 2.931

2.  Immunofluorescence Assay of Ablated Colorectal Liver Metastases: The Frozen Section of Image-Guided Tumor Ablation?

Authors:  Nikiforos Vasiniotis Kamarinos; Efsevia Vakiani; Sho Fujisawa; Mithat Gonen; Ning Fan; Yevgeniy Romin; Richard K G Do; Etay Ziv; Joseph P Erinjeri; Elena N Petre; Vlasios S Sotirchos; Juan C Camacho; Stephen B Solomon; Katia Manova-Todorova; Constantinos T Sofocleous
Journal:  J Vasc Interv Radiol       Date:  2021-11-17       Impact factor: 3.682

3.  Biopsy and Margins Optimize Outcomes after Thermal Ablation of Colorectal Liver Metastases.

Authors:  Nikiforos Vasiniotis Kamarinos; Efsevia Vakiani; Mithat Gonen; Nancy E Kemeny; Carlie Sigel; Leonard B Saltz; Karen T Brown; Anne M Covey; Joseph P Erinjeri; Lynn A Brody; Etay Ziv; Hooman Yarmohammadi; Henry Kunin; Afsar Barlas; Elena N Petre; Peter T Kingham; Michael I D'Angelica; Katia Manova-Todorova; Stephen B Solomon; Constantinos T Sofocleous
Journal:  Cancers (Basel)       Date:  2022-01-29       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.